KalVista to present HAE attack journey data at 2023 HAEi Regional conference

KalVista Pharmaceuticals announced the acceptance of multiple abstracts at the 2023 HAEi Regional Conference EMEA meeting taking place in Munich, Germany from September 1-3. KalVista is a Silver-level sponsor of the meeting. The presentations are: In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack Onset; and Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey. KalVista will also be launching a new patient-focused site called “Mind the HAE Attack” at HAEi EMEA on September 1.